Regulation of P-glycoprotein efflux activity by Z-guggulsterone of Commiphora mukul at the blood-brain barrier

被引:4
作者
Xu, Hong-Bin [1 ]
Yu, Jing
Xu, Lu-Zhong
Fu, Jun
机构
[1] Tongji Univ, Sch Med, Dept Pharm, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China
关键词
Z-guggulsterone; P-glycoprotein ATPase; Multidrug resistance-associated protein 1; Rhodamine; 123; MEDIATED MULTIDRUG-RESISTANCE; PENETRATION; EXPRESSION; REVERSAL; PROTEIN; INHIBITION; TRANSPORT; ATPASE;
D O I
10.1016/j.jns.2016.02.046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The present study was to investigate whether Z-guggulsterone had the regulatory effect on the activity and expression of P-glycoprotein in rat brain microvessel endothelial cells (rBMECs) and in rat brain. Inorganic phosphate liberation assay, high performance liquid chromatography, and western blot analysis were performed to assess the P-glycoprotein ATPase activity, the accumulation of NaF and rhodamine 123, and P-glycoprotein and MRP1 expression. The results showed that Z-guggulsterone (0-100 mu M) significantly enhanced basal P-glycoprotein ATPase activity in a concentration-dependent manner. Tetrandrine (0.1, 0.3,1 mu M) or cyclosporine A (0.1, 0.3, 1 mu M) had non-competitively inhibitory manner on Z-guggulsterone-stimulated P-glycoprotein ATPase activity, suggesting that Z-guggulsterone might have unique binding site or regulating site on P-glycoprotein. However, Z-guggulsterone (30, 100 mu M) had almost no influence on MRP1 expression in rBMECs. Further results revealed that Z-guggulsterone (50 mg/kg) significantly increased the accumulation of rhodamine 123 by down-regulating P-glycoprotein expression in rat brain, as compared with control (P < 0.05). Our studies suggested that Z-guggulsterone potentially inhibited the activity and expression of P-glycoprotein in rBMECs and in rat brain. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [31] Exploiting Transport Activity of P-Glycoprotein at the Blood-Brain Barrier for the Development of Peripheral Cannabinoid Type 1 Receptor Antagonists
    Wittgen, Hanneke G. M.
    Greupink, Rick
    van den Heuvel, Jeroen J. M. W.
    van den Broek, Petra H. H.
    Dinter-Heidorn, Heike
    Koenderink, Jan B.
    Russel, Frans G. M.
    MOLECULAR PHARMACEUTICS, 2012, 9 (05) : 1351 - 1360
  • [32] Regional P-Glycoprotein Activity and Inhibition at the Human Blood-Brain Barrier as Imaged by Positron Emission Tomography
    Eyal, S.
    Ke, B.
    Muzi, M.
    Link, J. M.
    Mankoff, D. A.
    Collier, A. C.
    Unadkat, J. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) : 579 - 585
  • [33] Assessment of P-glycoprotein Activity in the Blood-Brain Barrier (BBB) Using Near Infrared Fluorescence (NIRF) Imaging Techniques
    On, Ngoc H.
    Chen, Fang
    Hinton, Martha
    Miller, Donald W.
    PHARMACEUTICAL RESEARCH, 2011, 28 (10) : 2505 - 2515
  • [34] P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier
    Decaix, Theodore
    Vrillon, Agathe
    Paquet, Claire
    Laprevote, Olivier
    Lilamand, Matthieu
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DU VIEILLISSEMENT, 2024, 22 (02) : 137 - 144
  • [35] Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood-Brain Barrier
    Poller, Birk
    Drewe, Juergen
    Kraehenbuehl, Stephan
    Huwyler, Jorg
    Gutmann, Heike
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2010, 30 (01) : 63 - 70
  • [36] In Vitro and In Vivo Evidence for Amphotericin B as a P-Glycoprotein Substrate on the Blood-Brain Barrier
    Wu, Ji-Qin
    Shao, Kun
    Wang, Xuan
    Wang, Rui-Ying
    Cao, Ya-Hui
    Yu, Yun-Qiu
    Lou, Jin-Ning
    Chen, Yan-Qiong
    Zhao, Hua-Zhen
    Zhang, Qiang-Qiang
    Weng, Xin-Hua
    Jiang, Chen
    Zhu, Li-Ping
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (08) : 4464 - 4469
  • [37] Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model
    Ding, Yujie
    Zhong, Yu
    Baldeshwiler, Andrea
    Abner, Erin L.
    Bauer, Bjorn
    Hartz, Anika M. S.
    FLUIDS AND BARRIERS OF THE CNS, 2021, 18 (01)
  • [38] Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability
    O'Brien, Fionn E.
    Clarke, Gerard
    Dinan, Timothy G.
    Cryan, John F.
    Griffin, Brendan T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (10) : 2259 - 2272
  • [39] Rapid, Reversible Modulation of Blood-Brain Barrier P-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor
    Hawkins, Brian T.
    Sykes, Destiny B.
    Miller, David S.
    JOURNAL OF NEUROSCIENCE, 2010, 30 (04) : 1417 - 1425
  • [40] Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys
    Uchida, Yasuo
    Wakayama, Kentaro
    Ohtsuki, Sumio
    Chiba, Masato
    Ohe, Tomoyuki
    Ishii, Yasuyuki
    Terasaki, Tetsuya
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (03) : 578 - 588